This is a global, multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 3 trial that will compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.